Trials / Completed
CompletedNCT00729079
Diabetes Prevention Program Pilot Study
Virtual Translation of Diabetes Prevention to Primary Care: A Pilot Study
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 36 (actual)
- Sponsor
- University of Rochester · Academic / Other
- Sex
- All
- Age
- 18 Years – 90 Years
- Healthy volunteers
- Accepted
Summary
This pilot study is intended to demonstrate that we can actually deliver the Diabetes Prevention Program intervention well and to show that it is likely effective. We will use results from this pilot study to support our application to The National Institute of Health. NIH is asking for health care centers to show ways to provide this treatment at a reasonable cost. We propose to demonstrate successful and sustainable use DPP's lifestyle intervention in a primary care health care setting (University of Rochester Primary Care).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | DPP | 1. The primary outcome measure is weight loss with a goal of 7% of initial weight. 2. Secondary outcomes are adherence to behavior changes: 1. Exercising a minimum of 150 minutes per week at a moderate level to maintain an energy expenditure of 700 kcals per week 2. Fat intake less than 25% and saturated fat less than 10% 3. Fiber intake of at least 25 grams per day 4. Fasting blood sugar \< 100 mg/dL 5. Absence of tobacco use |
| BEHAVIORAL | DPP | 1. The primary outcome measure is weight loss with a goal of 7% of initial weight. 2. Secondary outcomes are adherence to behavior changes: 1. Exercising a minimum of 150 minutes per week at a moderate level to maintain an energy expenditure of 700 kcals per week 2. Fat intake less than 25% and saturated fat less than 10% 3. Fiber intake of at least 25 grams per day 4. Fasting blood sugar \< 100 mg/dL 5. Absence of tobacco use |
Timeline
- Start date
- 2008-12-01
- Primary completion
- 2009-07-01
- Completion
- 2009-10-01
- First posted
- 2008-08-06
- Last updated
- 2015-10-12
Locations
2 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00729079. Inclusion in this directory is not an endorsement.